Biomedical Software Startup BostonGene Secures $50M in Series A Financing from NEC
|
(Source: Global Banking And Finance Review) NEC Corporation (NEC; TSE: 6701) and BostonGene Corporation (BostonGene), a Boston, Mass-based biomedical software company, today announced a .